SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
SpyGlass Pharma has acquired Advanced Vision Science, Inc. (AVS) for ~$13 million to secure scalable manufacturing of intraocular lenses (IOLs) for its lead product, the BIM-IOL System, which is in two Phase 3 trials. The acquisition accelerates the company’s ability to develop premium lens options integrated with its sustained drug delivery techno…